866-997-4948(US-Canada Toll Free)

Global Vinpocetine Market Research Report 2017

Published By :

Gen Consulting

Published Date : Jul 2017

Category :


No. of Pages : 105 Pages

Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szntay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon.

The report covers forecast and analysis for the Vinpocetine market on a global and regional level. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both volumes and revenue. The study includes drivers and restraints for the Vinpocetine market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Vinpocetine market on a global level.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global Vinpocetine market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.

The study provides a decisive view on the Vinpocetine market by segmenting the market based on applications. All the application segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022.

Key Applications
Dietary Supplement

Key Regions
North America
Asia Pacific

Key Vendors
Covex/Pioneer Pharma
Alchem International
Vital Laboratories
Gedeon Richter
Jiangsu Swellxin Bio-Pharm
Chedom Pharmaceutical
Northeast Pharm

Key Questions Answered in this Report
What will the market size be in 2022?
What are the key factors driving the global Vinpocetine market?
What are the challenges to market growth?
Who are the key players in the Vinpocetine market?
What are the market opportunities and threats faced by the key players?
Part 1. Exclusive Summary

Part 2. Methodology
2.1 Research Methodology
2.2 Geographic Scope
2.3 Years Considered

Part 3. Introduction
3.1 Definition
3.2 Applications of Vinpocetine
3.2.1 Pharmaceutical
3.2.2 Dietary Supplement
3.3 Manufacturing Process

Part 4. Market Overview
4.1 Global Vinpocetine Market, by Volume 2012-2017
4.1.1 Overview
4.1.2 Global Vinpocetine Market, by Volume, by Company
4.1.3 Top 5 Companies by Volume Share
4.2 Global Vinpocetine Market, by Revenue 2012-2017
4.2.1 Overview
4.2.2 Global Vinpocetine Market, by Revenue, by Company
4.2.3 Top 5 Companies by Revenue Share
Part 5. Market Dynamics
5.1 Market Drivers
5.2 Challenges
5.3 Market Trends

Part 6. Segmentation by Application
6.1 Overview
6.2 Pharmaceutical
6.3 Dietary Supplement

Part 7. North America
7.1 North American Vinpocetine Market Size
7.2 by Country
7.2.1 United States
7.2.2 Canada

Part 8. Europe
8.1 European Vinpocetine Market Size
8.2 by Country
8.2.1 Germany
8.2.2 UK
8.2.3 France

Part 9. Asia-Pacific
9.1 Asia-Pacific Vinpocetine Market Size
9.2 by Country
9.2.1 China
9.2.2 Japan
9.2.3 India

Part 10. Chinese Vinpocetine Finished Dosage Market
10.1 Market Size
10.2 Market by Company
10.3 Prices
10.3 Consumption Balance
10.4 Chinese Key Vendors of Vinpocetine Finised Dosage
10.4.1 Runhong
10.4.2 Gedeon Richter
10.4.3 Zhitong

Part 11. Vinpocetine Market Forecast
11.1 Global Vinpocetine Market Size 2017-2022
11.2 Global Vinpocetine Market by Region 2017-2022
11.2.1 North America
11.2.2 Europe
11.2.3 Asia-Pacific
11.3 Global Vinpocetine Consumption 2017-2022
11.4 Global Vinpocetine Market by Application 2017-2022

Part 12. Company Profiles
12.1 Linnea.SA (Switzerland)
12.1.1 Business Overview
12.1.2 Products Offered
12.1.3 Financials
12.2 Covex.S.A. (Spain)
12.3 Alchem International (India)
12.4 Vital Laboratories (India)
12.5 Gedeon Richter (Hungary)
12.6 Jiangsu Swellxin Bio-Pharm (China)
12.7 Chedom Pharmaceutical (China)
12.8 Northeast Pharm (China)

Part 13. Appendix
13.1 Abbreviations
13.2 Disclaimer

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *